Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Arginine Methylation of BRD4 By CARM1 Regulates Its Function in AML

Adnan K. Mookhtiar, Hidehiro Itonaga, Sarah Greenblatt, Concepcion Martinez, Jun Sun, Krystal Lisa Hossack, Ramin Shiekhattar, Daniel Bilbao, Maria Ken E. Figueroa, Simone Sidoli, Stephen D. Nimer

Blood (2023) 142 (Supplement 1): 4112.

https://doi.org/10.1182/blood-2023-189759

Published: 2023

Journal Articles

Tyrosine Phosphorylation of CARM1 Promotes Its Enzymatic Activity and Alters Its Target Specificity in Myeloid Neoplasms with Hyperactivated JAK2

Hidehiro Itonaga, Adnan K Mookhtiar, Sarah Greenblatt, Fan Liu, Concepcion Martinez, Renata Grozovsky, Daniel Bilbao, Masai Rains, Pierre-Jacques Hamard, Jun Sun, Afoma Umeano, Stephanie Duffort, Chuan Chen, Na Man, Gloria Mas Martin, Stephen Schürer, Stephen D Nimer

Blood (2022) 140 (Supplement 1): 3021–3022.

https://doi.org/10.1182/blood-2022-156887

Published: 2022

Journal Articles

CARM1 Inhibition: Evaluation of Response and Efficacy in Acute Myeloid Leukemia

Adnan K Mookhtiar, BS, Sarah Greenblatt, PhD, Na Man, PhD, Daniel Karl, PhD, Vasileios Stathias, PhD, Stephan Schurer, PhD, Stephen D. Nimer, MD

Blood (2018) 132 (Supplement 1): 2719.

https://doi.org/10.1182/blood-2018-99-114981

Published: 2018

Journal Articles

PRMT5 Regulates DNA Repair By Controlling the Alternative Splicing of Epigenetic Factors

Pierre-Jacques Hamard, PhD, Gabriel Emmanuel Santiago, Fan Liu, PhD, Sarah Greenblatt, PhD, Daniel Karl, PhD, Concepcion Martinez, B.S., Ramiro E Verdun, PhD, Stephen D. Nimer, MD

Blood (2017) 130 (Supplement 1): 1148.

https://doi.org/10.1182/blood.V130.Suppl_1.1148.1148

Published: 2017

Journal Articles

CARM1/PRMT4 As a Novel Therapeutic Target for AML

Sarah Greenblatt, PhD, Na Man, Pierre-Jacques Hamard, PhD, Concepcion Martinez, B.S., Ye Xu, PhD, Fan Liu, PhD, Justin M Watts, MD, Daniel G. Tenen, MD, Stephen D. Nimer, MD

Blood (2017) 130 (Supplement 1): 241.

https://doi.org/10.1182/blood.V130.Suppl_1.241.241

Published: 2017

Journal Articles

FLT3 Inhibition and Retinoid Signaling Overcome Stromal Protection to Target FLT3/ITD-Expressing Leukemia Stem Cells in the Bone Marrow Microenvironment

Hayley S Ma, PhD, Megan E McCray, BA, Courtney M Shirley, PhD, Amy S. Duffield, MD PhD, J Kyle Bruner, Li Li, PhD, Bao Nguyen, M.S., Sarah Greenblatt, PhD, Eric Jung, BS, Peter D. Aplan, MD, Richard J Jones, MD, Donald Small, MD PhD, Gabriel Ghiaur, MD PhD

Blood (2015) 126 (23): 790.

https://doi.org/10.1182/blood.V126.23.790.790

Published: 2015

Journal Articles

TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo

Hayley Ma, Bao Nguyen, Li Li, Sarah Greenblatt, Allen Williams, Ming Zhao, Mark Levis, Michelle Rudek, Amy Duffield, Donald Small

Blood (2014) 123 (10): 1525–1534.

https://doi.org/10.1182/blood-2013-08-523035

Published: 2014

Includes: Supplemental data

Journal Articles

Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model

Sarah Greenblatt, Li Li, Christopher Slape, Bao Nguyen, Rachel Novak, Amy Duffield, David Huso, Stephen Desiderio, Michael J. Borowitz, Peter Aplan, Donald Small

Blood (2012) 119 (12): 2883–2894.

https://doi.org/10.1182/blood-2011-10-382283

Published: 2012

Includes: Supplemental data

Journal Articles

Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice

Li Li, Emily Bailey, Sarah Greenblatt, David Huso, Donald Small

Blood (2011) 118 (18): 4935–4945.

https://doi.org/10.1182/blood-2011-01-328096

Published: 2011

Journal Articles

Cytoplasmic Nucleophosmin (NPMc+) Mutations and FMS-Like Tyrosine Kinase 3 (Flt3) Internal Tandem Duplication (ITD) Mutations Cooperate to Cause Leukemia In a Mouse Model

Rachel E. Rau, MD, Daniel Magoon, Emily McIntyre, Li Li, PhD, Sarah Greenblatt, David Huso, DVM, PhD, Pier Paolo Pandolfi, MD, PhD, Donald Small, MD, PhD, Patrick Brown, MD

Blood (2010) 116 (21): 145.

https://doi.org/10.1182/blood.V116.21.145.145

Published: 2010

NARROW

Arginine Methylation of BRD4 By CARM1 Regulates Its Function in AML

Tyrosine Phosphorylation of CARM1 Promotes Its Enzymatic Activity and Alters Its Target Specificity in Myeloid Neoplasms with Hyperactivated JAK2

CARM1 Inhibition: Evaluation of Response and Efficacy in Acute Myeloid Leukemia

PRMT5 Regulates DNA Repair By Controlling the Alternative Splicing of Epigenetic Factors

CARM1/PRMT4 As a Novel Therapeutic Target for AML

FLT3 Inhibition and Retinoid Signaling Overcome Stromal Protection to Target FLT3/ITD-Expressing Leukemia Stem Cells in the Bone Marrow Microenvironment

TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo

Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model

Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice

Cytoplasmic Nucleophosmin (NPMc+) Mutations and FMS-Like Tyrosine Kinase 3 (Flt3) Internal Tandem Duplication (ITD) Mutations Cooperate to Cause Leukemia In a Mouse Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only